Centene Corporation (CNC) Stock Analysis 2026

HealthcareHealthcare Plans
$68.62
as of 2026-10-29
+103.5% (52-week)50D MA $65.27  |  200D MA $49.73

BriMind AI Score

Proprietary
44
Neutral
Price CAGR
8.3%
1Y Return
+106.0%
Analyst Upside
+2.1%
Rev Growth
4.6%

Score based on historical price CAGR, revenue growth, analyst upside, and valuation factors. Updated daily.

AI scores and price targets are for informational and educational purposes only. They do not constitute financial advice or a recommendation to buy or sell any security. Past performance is not indicative of future results. Always conduct your own research before making investment decisions. Full Disclaimer →

CNC Revenue & Profitability Breakdown

This chart shows how CNC's revenue flows through to profit. Each row deducts a layer of costs: first the direct cost of making products/services (Cost of Revenue), then operating expenses like marketing and R&D, then taxes. What remains at the bottom is net income — the actual profit shareholders own. High gross and net margins indicate a business with strong pricing power and efficiency.

Revenue
$180.30B
Cost of Revenue
-$159.72B
Gross Profit
$20.58B11.4% margin
Operating Expenses
-$13.80B
Operating Income
$6.78B3.8% margin
Tax & Other
-$11.88B
Net Income
-$-5.10B-2.8% margin
Gross Margin
11.4%
Operating Margin
3.8%
Net Margin
-2.8%

Key Financial Metrics

Centene Corporation trades at a trailing P/E of 9.06x, generates $9.64B in free cash flow, runs a debt/equity ratio of 71.08, and converts shareholder equity into profit at a -20.4% return on equity. For context: P/E ratio measures how much you pay for $1 of earnings (lower = cheaper, but fast-growing companies command higher P/E); Free Cash Flow is the cash left after running the business; Debt/Equity shows how leveraged a company is; Return on Equity shows how efficiently it turns shareholder capital into profit.

Market Cap
$31.99B
P/E (Trailing)
9.06
P/E (Forward)
12.19
PEG Ratio
0.88
Revenue
$180.30B
Revenue Growth
4.6%
Earnings Growth
18.3%
Gross Margin
11.4%
Operating Margin
3.8%
Net Margin
-2.8%
Return on Equity
-20.4%
Return on Assets
2.5%
Free Cash Flow
$9.64B
Debt / Equity
71.08
Current Ratio
1.15
Quick Ratio
1.11
Beta
1.10
Dividend Yield
None
Payout Ratio
0.0%
Insider Ownership
0.4%
Inst. Ownership
101.4%
Short % Float
3.1%
Book Value / Share
$45.67

Wall Street Analyst Consensus

Wall Street analysts covering Centene Corporation currently haven't converged on a clear consensus rating, with a mean 12-month price target of $71.67 (+4.4% vs the current price). Analysts set these targets after researching a company's earnings, competitive position, and industry trends — Strong Buy / Buy means the majority expect meaningful upside, while Hold means fair value near the current price rather than a sell signal.

Mean Target$71.67+4.4% upside

Technical Price Signals

CNC is currently in a golden cross pattern, trading above its 50-day average of $65.27 and above its 200-day average of $49.73. Moving averages smooth out day-to-day volatility to reveal the underlying trend — a Golden Cross (50MA crosses above 200MA) is a classic bullish signal, a Death Cross is bearish, though both are lagging indicators that confirm trends rather than predict them.

Current Price
$68.62
50-Day MA
$65.27
▲ Price above
200-Day MA
$49.73
▲ Price above
Golden Cross Pattern
Price above both MAs — bullish signal
Read the full CNC in-depth report
Seven-method valuation, AI Score, blended price target, and a 5-year Monte Carlo simulation for CNC.

Compare CNC with Peers

CNC vs MOHCentene vs Molina Healthcare — Two Medicaid-Focused Man
CNC vs HUMCentene vs Humana — Medicaid Specialist vs Medicare Adv
CNC vs CICentene vs Cigna — Government Managed Care vs Diversifi
HCA vs CNCHCA Healthcare vs Centene — Hospital Operator vs Govern
CNC vs ELVCentene vs Elevance Health — Medicaid Specialist vs Div
CNC vs MCKCentene vs McKesson — Medicaid Insurer vs Pharmaceutica
CNC vs ZTSCentene vs Zoetis — Medicaid Insurer vs Animal Health P
UNH vs CNCUnitedHealth vs Centene — Diversified Health Insurer vs

Further Reading

Research and guides that put CNC’s numbers in context — how to read the filings behind them, and the frameworks we use to score them.

Risk ManagementBest ETFs for a Recession-Proof Portfolio in 2026FundamentalsHow to Read a 10-K Annual Report: Complete Investor GuideFundamentals10 Stock Analysis Tools Every Investor Should Know AboutFundamentalsFactor Investing Guide 2026: Value, Momentum, Quality & Low Volatility — Which Factors Work?

More Healthcare Stock Analysis

In-depth reports on companies operating alongside CNC — business models, bull and bear cases, and the metrics that matter.

CVSCVS Health CorporationHealthcare PlansMOHMolina Healthcare, Inc.Healthcare PlansUNHUnitedHealth Group IncorporatedHealthcare PlansHUMHumana Inc.Healthcare PlansDHRDanaher CorporationDiagnostics & ResearchVRTXVertex Pharmaceuticals IncorporatedBiotechnologyCAHCardinal Health, Inc.Medical DistributionMDTMedtronic plcMedical Devices

Unlock the Full CNC Analysis

Interactive price charts, real-time AI signals, advanced DCF models, portfolio tracking, earnings analysis, and side-by-side peer comparisons. Start your 14-day free trial — no credit card required.

Start Free TrialBrowse All Stocks
Data sources: Financial metrics and market data sourced from company SEC filings, earnings releases, and investor relations disclosures. Price data, analyst consensus targets, and fundamental financials provided by financial market data providers. ETF data sourced from official fund prospectuses and index provider publications. AI scores and price targets are proprietary estimates — see our Methodology and Disclaimer for details.
← Back to Home · Browse All Stock Analysis